SPN and cancer: Notably, the absence of significant changes in ETC complex activities (Fig. 3K, Fig. S2) underscores that Spn-H2O2 targets upstream TCA cycle enzymes rather than the ETC itself, a mechanism distinct from the ETC decline associated with human diseases like neurodegeneration, cancer, and diabetes (57).